• US: +1-408-610-2300
  • Toll Free: +1-866-831-4085
  • Login / Register
Cardiac Marker Testing Market Size, 2018 | Global Industry Report

Cardiac Marker Testing Industry 2018 Market Research Report

Report ID: MN17614637  |  Published: January 2017  |  No of Pages: 102
Format: Electronic (PDF)  |  Industry: Medical Devices  |  Publisher: QY Research

The global cardiac marker testing market is portraying exponential growth at a high CAGR in forthcoming period due to growing incidence of cardiovascular diseases.Research on cardiac biomarkers and rising prevalence and incidence of cardiac disease are the major factors driving growth in cardiac marker testing markets.Cardiac Bio-marker diagnostic test market is used to determine the concentration of proteins also used in measuring occurrence and phase of cardiovascular disease (CVD).

Growing prevalence of cardiovascular diseases, rapidly growing geriatric population and growing funds from private-public funded organizations to conduct ongoing trials are fueling the growth of cardiac markers testing market.The major causes of CVD are smoking, high Blood Pressure, diabetes, sedentary lifestyle, unhealthy diet, high cholesterol and obesity.However, factors such as technical problems related to collection of samples and storage and issues in relation to regulatory and reimbursement systems are key factors hindering growth of the market.

Developing countries such as India and China have proved to be popular for companies developing cardiac biomarkers. Prevalence of cardiovascular diseases are significant in driving growth of cardiac biomarker testing market.China is top nation in CVD mortality rates and of importance here is that biomarkers help in early diagnosis of disease and hence help doctors and clinicians around the world with technological advances among doctors and clinicians talked in seminars are propelling demand for cardiac biomarkers in emerging markets.

Segmentation of cardiac marker testing market by type includes Troponin CK MB, MYoglobin, Brain Naturerteic peptide or NTpro BNPandC-reactive protein. By product, cardiac marker testing market includes instruments, chemiluminiscence, imunoflursecence, ELISA and reagents and kits.By disease, cardiac marker testing market includes myocardialinfection and congestive heart failure.By type of testing, cardiac marker testing market includes laboratory testing and point-of-care testing.By geographical regions, cardiac marker testing market includes North America, Europe, Asia pacific, MEA and Latin America.North America holds largest share of cardiac marker testing market followed by Europe. Asia Pacific is expected to gain maximum lead in markets in forecast period.

Cardiac biomarker tests measure the concentration of certain proteins called biomarkers which indicate the severity of cardiovascular disease. Among the most prominent of CVD are sudden cardiac arrest (SCA), acute myocardial infection (AMI), congestive heart failure (CHF) and atheroscelrosis. The most attractive of cardiac marker growth areas include the cardiac rapid assay market.Key players have entered into agreements, partnerships and have embarked on product launches and showcased products to ensure market dominance.The key industry players in cardiac marker testing market include Roche Diagnostics, Abott Laboratories and Siemens AG, Danahe Corporation, LSI MED science Corporation.

Market Segment:

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of cardiac marker Testing in these regions, from 2013 to 2025 (forecast), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Cardiac Marker Testing market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• Roche Diagnostics
• Abbott Laboratories
• Siemens
• Danaher Corporation
• Alere Inc
• BioMerieux
• LSI Medience Corporation
• Ortho Clinical Diagnostics
• Randox Laboratories Ltd
• Guangzhou Wondfo Biotech

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Chemiluminescence
• Immunofluorescence
• ELISA
• Immunochromatography
• Other

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Pharmaceutical Companies
• Reagents Manufacturers
• Imaging Instrument Providers
• Other

What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service
  • 100% Secure Payments
  • Our Promise
  • 100% Service Assurance
  • Market Monitoring
  • Service Flexibility
  • 24X5 Care available